GLP-1 drug surge strains healthcare system

The rapid expansion of GLP-1 medication usage is creating affordability and logistics challenges across the U.S. healthcare system, with insurers cutting coverage due to cost pressures while shipping companies race to build specialized cold-chain infrastructure to meet growing demand.

This is a long-running storyline that has developed over 13 days. The homepage highlights its most recent activity, so the outlet count there reflects the latest wave. The totals above cover the full run.